Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) just unveiled an announcement.
Shandong Weigao Group Medical Polymer Company Limited announced proposed amendments to its Articles of Association to align with recent legal and regulatory changes, including the flexibility to manage treasury shares and facilitate electronic voting in shareholder meetings. Additionally, the company plans to implement full circulation of its H shares, converting 48,300,000 unlisted shares into H shares, pending necessary approvals, which could enhance liquidity and market presence.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in China, operating in the medical polymer industry. The company focuses on manufacturing and distributing medical devices and equipment, catering to healthcare markets.
YTD Price Performance: 24.08%
Average Trading Volume: 14,674,512
Technical Sentiment Signal: Sell
Current Market Cap: HK$25.19B
For an in-depth examination of 1066 stock, go to TipRanks’ Overview page.